We are live on ! Find out more
LNAI

Lunai Bioworks

20 hedge funds and large institutions have $1.38M invested in Lunai Bioworks in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.04% less ownership

Funds ownership: 0.1%0.06% (-0.04%)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

52% less funds holding

Funds holding: 4220 (-22)

67% less capital invested

Capital invested by funds: $4.17M → $1.38M (-$2.79M)

88% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 25

Holders
20
Holders Change
-22
Holders Change %
-52.38%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
7
Closed
25
Calls
$53K
Puts
Net Calls
+$53K
Net Calls Change
+$22K

LNAI Hedge Fund Activity: Q3 2025 in Review

20 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q3 2025, worth a combined $1.38M — down 67% from $4.17M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of LNAI and 3 opened new positions — a net loss of 22 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $91K. The largest seller was BlackRock, cutting an estimated $343K.

  • 20 institutional investors held Lunai Bioworks (LNAI) as of Q3 2025, down from 42 in Q2 2025.
  • Funds reported $1.38M of Lunai Bioworks stock for Q3 2025, down 67% quarter-over-quarter.
  • 3 funds opened new Lunai Bioworks positions in Q3 2025 and 25 closed out, a net change of -22 holders.
  • The largest Lunai Bioworks buyer in Q3 2025 was Renaissance Technologies, an estimated $91K added.
  • The largest Lunai Bioworks seller in Q3 2025 was BlackRock, an estimated $343K sold.

Based on aggregated 13F filings for Q3 2025.